Toxic shock syndrome: Experience in a pediatric intensive care unit;Síndrome de shock tóxico: Experiencia en una UCIP

Anales de Pediatria

Volumn 66, Issue 6, 2007, Pages 566-572

  Costa Orvay, J A ^a,b   Caritg Bosch, J ^a   Morillo Palomo, A ^a   Noguera Julian T ^a   Esteban Torne, E ^a   Palomeque Rico, A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL SANT JOAN DE DÉU   (Spain)

Author keywords

Pediatrics; Staphylococcus; Streptococcus; Toxic shock syndrome

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; CREATINE KINASE; IMMUNOGLOBULIN;

ARTICLE; ASSISTED CIRCULATION; ASSISTED VENTILATION; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; CREATINE KINASE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; ERYTHRODERMA; FEMALE; FEVER; HUMAN; HYPOTENSION; INTENSIVE CARE; KIDNEY FAILURE; LABORATORY TEST; LETHARGY; LEUKOCYTE COUNT; MALE; MICROCLIMATE; MULTIPLE ORGAN FAILURE; RASH; RETROSPECTIVE STUDY; SCHOOL CHILD; SHOCK; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIA; TOXIC SHOCK SYNDROME; TREATMENT OUTCOME;

EID: 34547635065     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1157/13107390     Document Type: Article

References (37)

1. Todd J, Fishaut M, Kapral F, Welch T. Toxic shock syndrome associated with phage-group 1 staphilococci. Lancet. 1978,2:1116-8.
2. Hajjeh RA, Reingold A, Weil A, Shutt K, Schuchat A, Perkins BA. Toxic shock syndrome in the United States: Surveillance update, 1979 1996. Emerg Infect Dis. 1999;5:807-10.
3. Shands KN, Schmid GL, Dan GB, Blum D. Toxic shock syndrome in menstruating women. Association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med. 1980;303:1436-42.
4. Castañón L, Martínez JP, Marugan JM, et al. Rabdomiólisis y síndrome del shock tóxico asociado a herida cutánea. Act Pediatr Esp. 2001;59:596-9.
5. Marchant B, Brown J. Síndrome del shock tóxico y neumonía estafilocócica. Lancet (Ed. esp.). 1982;1:1-4.
6. Wilkins EGL, Nye F, Roberts C, De Saxe M. Probable toxic shock with primary staphylococcal pneumonia. J Infect Dis. 1985;11:231-2.
7. Brown AP, Khan K, Sinclair S. Bacterial toxicosis/toxic shock syndrome as a contributor to morbidity in children with burn injuries. Burns. 2003;29:733-8.
8. Edwards-Jones V, Dawson MM, Childs C. A survey into toxic shock syndrome (TSS) in UK burns units. Burns. 2000;26:323-33.
9. Watkins R, Vyas H. Toxic shock syndrome and streptococcal myositis: Three case reports. Eur J Pediatr. 2002;161:497-8.
10. Cawley MJ, Briggs M, Haith LR Jr, Reilly KJ, Guilday RE, Braxton GR, et al. Intravenous immunoglobulin as adjunctive treatment for streptococcal toxic shock syndrome associated with necrotizing fasciitis: Case report and review. Pharmacotherapy. 1999;19:1094-8.
11. De Vincente Aymat A, Martínez de Azagra A, Mencia Bartolomé S, Serrano González A, Casado Flores J. Síndrome del shock tóxico en niños. Presentación de 4 casos. An Esp Pediatr. 2000;52:263-6.
12. Wood SD, Ries K, White GL Jr, Murdock RT, Pedersen DM. Maxilary sinusitis - the focus of toxic shock syndrome in a male patient. West J Med. 1987;147:467-9.
13. Grimies J, Carpenter C, Reinker K. Toxic shock syndrome as a contributor of orthopaedic surgery. J Pediatr Orthop. 1995;15:666-71.
14. Cone AL, Woodard DR, Schlievert PM, Tomory GS. Clinical and bacteriological observation of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med. 1987;317:146-9.
15. Floret D, Stamm D, Cochart P, Delmas P, Kohler W. Streptococcal toxic syndrome in children. Intens Care Med. 1992;18:175-6.
16. Huang YC, Hsueh PR, Lin TY, Yan DC, Hsia SH. A family cluster of streptococcal toxic shock syndrome in children: Clinical implication and epidemiological investigation. Pediatrics. 2001;107:1181-3.
17. Lina G, Fleer A, Etienne J, Greenland TB, Vandenesch F. Coagulase-negative staphylococci isolated from two cases of toxic shock syndrome lack superantigenic activity, but induce cytokine production. FEMS Immunol Med Microbiol. 1996;13:81-6.
18. Kahler RC, Boyce JM, Bergdoll MS, Lockwood WR, Taylor MR. Toxic shock syndrome associated with TSST-1 producing coagulase-negative Staphylococci. Am J Med Sci. 1986;292:310-2.
19. Crass BA, Bergdoll MS. Involvement of coagulase-negative staphylococci in toxic shock syndrome. J Clin Microbiol. 1986;23:43-5.
20. Christensson B, Hedstrom SA. Serological response to toxic shock shock syndrome toxin in Staphylococcus aureus infected patients and healthy controls. Acta Pathol Microbiol Immunol Scand B. 1985;93:87-90.
21. Centers for Disease Control. Case definitions for public health surveillance. MMWR. 1990;39:38-9.
22. The working group on severe streptococcal infections. Defining the group a streptococcal toxic shock syndrome. JAMA. 1993;269:390-1.
23. Centers for Disease Control. Reduced incidence of menstrual toxic-shock syndrome: United States, 1980-1990. MMWR Morb Mortal Wkly Rep. 1990;39:421-3.
24. Friedstrom SR, Awad J. Toxic-shock-like-syndrome due to Streptococcus pneumoniae sinusitis. Scand J Infect Dis. 1999;31:509-10.
25. Fast DJ, Schlievert PM, Nelson RD. Toxic shock syndrome-associated staphilococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor productions. Infect Immun. 1989;57:291-4.
26. Javid KV, Rogan MT, Edwards-Jones V, Foster HA. Detection of antibodies to Staphylococcus aureus Toxic Shock Syndrome Toxin-1 using a competitive agglutination inhibition assay. Lett Appl Microbiol. 2003;36:372-6.
27. Rivera JM, García-Bragado F, Jiménez P, Rodríguez J, Lozano F, Grilo A. Síndrome del shock tóxico frente al síndrome de Kawasaki. Dificultades diagnósticas. Med Clin (Barc). 1992;98:458-60.
28. Hansen RC. Staphylococcal scalded skin syndrome, toxic shock syndrome, and Kawasaki disease. Pediatr Clin North Am. 1983;30:533-44.
29. Todd J. Therapy of toxic shock syndrome. Drugs. 1990;39:856-61.
30. Davis JP, Chesney PJ, Wand PJ, La Venture. Toxic-shock syndrome: Epidemiologic features, recurrente, risk factor and prevention. N Engl J Med. 1980;303:1429-35.
31. Darenberg J, Soderquist B, Normark BH, Norrby-Teglund A. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal superantigens: Implications for therapy of toxic shock síndrome. Clin Infect Dis. 2004;38:836-42.
32. Murthy BV, Nelson RA, Mannion PT. Immunoglobulin therapy in non-menstrual streptococcal toxic shock syndrome. Anaesth Intensive Care. 2003;31:320-3.
33. Todd Jk, Ressman M, Caston SA, Todd BH, Wiesenthal AM. Corticosteroid therapy for patients with toxic shock syndrome. JAMA. 1984;252:3399-402.
34. Darenberg J, Ihendyane N, Sjolin J, Aufwerber E, Haidl S, Follin P, et al; StreptIg Study Group. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: A European randomized, double blind, placebo controlled trial. Clin Infect Dis. 2003;37:333-40.
35. Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, O'Rourke K, et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome. A comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis. 1999;28:800-7.
36. Andrews MM, Parent EM, Barry M, Parsonnet J. Recurrent nonmenstrual toxic shock syndrome: Clinical manifestations, diagnosis, and treatment. Clin Infect Dis. 2001;32:1470-9. Epub 2001 Apr 18.
37. Floret D. Clinical aspects of streptococcal and staphylococcal toxinic disease. Arch Pediatr. 2001;8 Suppl 4:762-8.